Skip to main content

BI Logo 390 25/5 (Trijardy XR empagliflozin 25 mg / linagliptin 5 mg / metformin hydrochloride 1000 mg extended-release)

Generic Name: empagliflozin/linagliptin/metformin

Pill with imprint BI Logo 390 25/5 is Brown, Elliptical / Oval and has been identified as Trijardy XR empagliflozin 25 mg / linagliptin 5 mg / metformin hydrochloride 1000 mg extended-release. It is supplied by Boehringer Ingelheim and Eli Lilly and Company.

Trijardy XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Trijardy XR empagliflozin 25 mg / linagliptin 5 mg / metformin hydrochloride 1000 mg extended-release is not a controlled substance under the Controlled Substances Act (CSA).

Images for BI Logo 390 25/5

Trijardy XR empagliflozin 25 mg / linagliptin 5 mg / metformin hydrochloride 1000 mg extended-release BI Logo 390 25/5

Trijardy XR

Generic Name
empagliflozin/linagliptin/metformin
Imprint
BI Logo 390 25/5
Strength
empagliflozin 25 mg / linagliptin 5 mg / metformin hydrochloride 1000 mg extended-release
Color
Brown
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Boehringer Ingelheim and Eli Lilly and Company
National Drug Code (NDC)
00597-0390

Get help with Imprint Code FAQs.

More about Trijardy XR (empagliflozin / linagliptin / metformin)

Consumer resources

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.